GNH USA

Europe — EMA

Padoview (Fluorodopa (18f))

Fluorodopa, the active ingredient in Padoview, is a radiopharmaceutical presented as a unknown/unknown for intravenous use. It is used in diagnostic imaging to assess neurological conditions, particularly in patients…

Request sourcing

1
Pack/s

What is Fluorodopa (18f)?

Fluorodopa, the active ingredient in Padoview, is a radiopharmaceutical presented as a unknown/unknown for intravenous use. It is used in diagnostic imaging to assess neurological conditions, particularly in patients undergoing neurodegenerative disease evaluation. GNH USA supplies Padoview as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Padoview as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Fluorodopa (18f) used for?

Padoview is a radiopharmaceutical used primarily for imaging the dopaminergic pathways of the brain in the following conditions:

- Parkinson Disease: It helps to visual the distribution of presynaptic dopamine transporters in the brain and supports diagn diagn diagn . -   

What are the side effects of Fluorodopa (18f)?

Common  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Fluorodopa (18f)
Route
Intravenous Use
Manufacturer
Advanced Accelerator Applications Molecular Imaging France S.A.S.
Origin
EU

Related products